Four studies reported the sFlt-1/PlGF ratio among COVID-19 positive patients vs. control group, two in asymptomatic vs. symptomatic groups, three in severe vs. non-severe COVID-19 and two among COVID-19 patients with hypertensive disease of pregnancy vs. non-HDP. Here, PGF is linked to COVID-19.